<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03843307</url>
  </required_header>
  <id_info>
    <org_study_id>STU 042018-005</org_study_id>
    <nct_id>NCT03843307</nct_id>
  </id_info>
  <brief_title>Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study</brief_title>
  <official_title>Study to Evaluate the Tennant Biomodulator® PRO Device Designed by AVAZZIA Effects on Perfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avazzia, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lawrence A. Lavery, DPM, MPH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kathryn Davis, Ph.D.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Avazzia, Inc</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an open label trial designed to test the effectiveness of the Tennant
      Biomodulator® PRO electrical stimulation device (Avazzia), which uses BEST™ (Bio-Electric
      Stimulation Technology), on hospital in-patients to improve perfusion in the treated and
      contralateral limb.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2019</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in perfusion up to 3 hours</measure>
    <time_frame>3 hours</time_frame>
    <description>Change in skin perfusion will be assessed by Skin Perfusion Pressure Test (SPP)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in perfusion up to 3 hours</measure>
    <time_frame>3 hours</time_frame>
    <description>Change in skin perfusion will be assessed by Hyperspectral Imaging (HSI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of BEST-induced perfusion effects</measure>
    <time_frame>3 hours</time_frame>
    <description>To compare the duration of BEST™ (Bio-Electric Stimulation Technology) induced perfusion effects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in reported pain after BEST™ (Bio-Electric Stimulation Technology) administration, at the point perfusion returns to baseline, and at 24 hours after treatment</measure>
    <time_frame>24 hours</time_frame>
    <description>Pain will be assessed with the Visual Analog Scale (VAS) labeled from '0': no pain to '10': worst pain imaginable</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Perfusion; Complications</condition>
  <condition>Wound; Foot</condition>
  <arm_group>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Avazzia Tennant Biomodulator® PRO</intervention_name>
    <description>High-voltage pulsed current (HVPC) electrical stimulation with Reactions and BEST™ (Bio-Electric Stimulation Technology) microcurrent that measure and change with tissue electrical characteristics.</description>
    <arm_group_label>Electrical stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to provide Informed Consent

          -  Ankle Brachial Index (ABI) ≥ 0.5 (bedside ABI is acceptable for screening purposes as
             the formal imaging ABI may not be resulted prior to therapy)

          -  Participant is a hospital in-patient for the duration of study procedures

          -  One or more chronic lower extremity wounds that are located in the ankle area or below
             that has persisted a minimum of 30 days prior to the Screening visit

          -  18 years of age or older

        Exclusion Criteria:

          -  Unable to provide informed consent

          -  &lt;18 years of age

          -  Participant has a demand-type cardiac pacemaker, implanted defibrillator or other
             implanted metallic or electronic device.

          -  Participant has untreated osteomyelitis

          -  Participant has active cellulitis

          -  Participant has active charcot

          -  Is pregnant or plans to become pregnant

          -  Is nursing or actively lactating

          -  Developmental disability/significant psychological disorder that in the opinion of the
             investigator could impair the participant's ability to provide informed consent,
             participate in the study protocol including untreated schizophrenia, bipolar disorder
             and psychiatric hospitalization within the last 2 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence A Lavery, DPM, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center, Department of Plastic Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tammy Lahutsky</last_name>
    <phone>214-575-2820</phone>
    <email>tlahutsky@avazzia.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center, Department of Plastic Surgery</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lawrence A Lavery, DPM, MPH</last_name>
      <phone>214-645-7900</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Thakral G, Lafontaine J, Najafi B, Talal TK, Kim P, Lavery LA. Electrical stimulation to accelerate wound healing. Diabet Foot Ankle. 2013 Sep 16;4. doi: 10.3402/dfa.v4i0.22081. Review.</citation>
    <PMID>24049559</PMID>
  </reference>
  <reference>
    <citation>Peters EJ, Armstrong DG, Wunderlich RP, Bosma J, Stacpoole-Shea S, Lavery LA. The benefit of electrical stimulation to enhance perfusion in persons with diabetes mellitus. J Foot Ankle Surg. 1998 Sep-Oct;37(5):396-400; discussion 447-8.</citation>
    <PMID>9798171</PMID>
  </reference>
  <reference>
    <citation>Nair HKR. Microcurrent as an adjunct therapy to accelerate chronic wound healing and reduce patient pain. J Wound Care. 2018 May 2;27(5):296-306. doi: 10.12968/jowc.2018.27.5.296.</citation>
    <PMID>29738296</PMID>
  </reference>
  <reference>
    <citation>Andrushko JW, Lanovaz JL, Björkman KM, Kontulainen SA, Farthing JP. Unilateral strength training leads to muscle-specific sparing effects during opposite homologous limb immobilization. J Appl Physiol (1985). 2018 Apr 1;124(4):866-876. doi: 10.1152/japplphysiol.00971.2017. Epub 2017 Dec 14.</citation>
    <PMID>29357520</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 7, 2019</study_first_submitted>
  <study_first_submitted_qc>February 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electrical stimulation</keyword>
  <keyword>Perfusion</keyword>
  <keyword>Foot wound</keyword>
  <keyword>Foot pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Foot Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunologic Factors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

